Krebs Biochemicals and Industries Q3FY22 net loss at Rs. 12.94 crores

Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 22.0113 crores during the period ended December 31, 2021 as compared to Rs. 12.1121 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. -12.9409 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -10.8485 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. -6 for the period ended December 31, 2021 as compared to Rs. -5.05 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 22.0113 crs	₹12.1121 crs	81.73%
Net Profit	₹-12.9409 crs	₹-10.8485 crs	19.29%
EPS	₹-6	₹-5.05	18.81%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 22.0113 crores during the period ended December 31, 2021 as compared to Rs.9.6336 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-12.9409 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-8.2602 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.-6 for the period ended December 31, 2021 as compared to Rs.-4.21 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 22.0113 crs	₹9.6336 crs	128.48%
Net Profit	₹-12.9409 crs	₹-8.2602 crs	56.67%
EPS	₹-6	₹-4.21	42.52%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.40.9086 crores during the 9 Months period ended December 31, 2021 as compared to Rs.38.0183 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-33.2130 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-21.3720 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.-15.42 for the 9 Months period ended December 31, 2021 as compared to Rs.-10.89 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹40.9086 crs	₹38.0183 crs	7.60%
Net Profit	₹-33.2130 crs	₹-21.3720 crs	55.40%
EPS	₹-15.42	₹-10.89	41.60%

Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 144.45 as compared to the previous close of Rs. 154.60. The total number of shares traded during the day was 5681 in over 171 trades.

The stock hit an intraday high of Rs. 155.00 and intraday low of 141.00. The net turnover during the day was Rs. 843755.00.

Source : Equity Bulls

Keywords

KrebsBiochemicalsandIndustries Q3FY22 9MFY22 ResultUpdate